The FREND COVID-19 SP is a point-of-care test (POCT) which can be used to check whether patient has developed immune response to SARS-CoV-2 using human serum or plasma. The fluorescence immunoassay (FIA) uses the FREND System intended for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2. The test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.